Our vision

Contact us

The company's vision is to globally reduce mortality, increase quality of life and reduce patient care costs by enabling a paradigm shift in early diagnosis of ovarian cancer through:

unmatched performance regarding sensitivity and specificity.

VOC Diagnostics AB plans to introduce the method at the beginning in the Swedish market since there are existing contacts and good market knowledge. The strategy for the business model is under development and will be presented during Q2/Q3, 2019.